🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension

Recruitingn/aAges 18 Years - 80 YearsAllFirst Affiliated Hospital of Wannan Medical Colle…
NCT07033273 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This multicenter, prospective observational study aims to evaluate the predictive value of the Inferior Vena Cava Collapsibility Index (IVCCI), along with IVC maximum diameter (IVCmax) and IVC minimum diameter (IVCmin), for intradialytic hypotension in patients undergoing maintenance hemodialysis. The study will be conducted at The First Affiliated Hospital of Wannan Medical College, Wuhu City Second People's Hospital, Wuhu Hospital of Chinese Traditional Medicine, Wuhu Jinghu District Hospital, and Wuhu Guangji Hospital. Eligible participants are adults aged 18 years or older with diagnosed end-stage renal disease (ESRD), receiving regular hemodialysis for at least three months. Patients with acute kidney injury, severe cardiac conditions, or other factors likely to influence results will be excluded. Ultrasound measurements of IVCCI, IVCmax, and IVCmin will be performed once, precisel

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older. * Diagnosed with end-stage renal disease (ESRD). * Undergoing regular hemodialysis for at least three months. Exclusion Criteria: * Pregnant or breastfeeding women. * Hemodynamically unstable patients or those requiring vasopressor support. * Patients with severe cardiac conditions, including congestive heart failure -classified as NYHA Class III-IV or severe valvular disease. * Patients with known allergies to dialysis filters. * Dialysis sessions terminated for reasons unrelated to hypotension (e.g., technical issues, patient request). * Patients who withdraw informed consent during the study. * Use of antihypertensive medications during dialysis sessions. * Inability to undergo ultrasound assessment due to factors such as severe obesity or wounds obstructing access.
💊

What it tests

  • Non-invasive Monitoring
📍

Where

1 site
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Wuhu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy